N | All | Males | Females | Unknown gender | Medulloblastoma | ATRT | Germinoma | Controls | Mean age (years) | STDEV AGE | Mean Age (weeks) | STDEV age | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Meta-analysis | ALL | 161 | 4.15 | 11.91 | 226.32 | 574.91 | |||||||
MALES | 82 | 3.85 | 13.76 | 210.26 | 663.33 | ||||||||
FEMALES | 46 | 1.09 | 2.43 | 76.16 | 122.39 | ||||||||
UNKNOWN GENDER | 32 | 9.20 | 14.00 | 476.79 | 672.56 | ||||||||
MEDULLOBLASTOMA | 19 | 8 | 7 | 4 | 6.89 | 4.13 | 366.95 | 198.43 | |||||
ATRT | 8 | 1 | 3 | 4 | 2.23 | 2.18 | 142.95 | 104.49 | |||||
GERMINOMA | 12 | 0 | 0 | 12 | 11.15 | 3.08 | 571.00 | 147.76 | |||||
CONTROLS | 121 | 73 | 36 | 12 | 3.04 | 13.43 | 169.45 | 647.52 | |||||
FETAL | 76 | 40 | 32 | 4 | 0 | 0 | 0 | 76 | 0.00 | 0.00 | 18.39 | 3.41 | |
INFANT | 19 | 15 | 4 | 0 | 1 | 2 | 0 | 16 | 0.56 | 0.54 | 62.67 | 25.71 | |
CHILD | 40 | 9 | 10 | 21 | 15 | 6 | 9 | 10 | 5.82 | 3.52 | 315.53 | 168.84 | |
ADOLESCENT | 6 | 3 | 0 | 3 | 3 | 0 | 3 | 0 | 14.07 | 1.57 | 711.54 | 75.34 | |
ADULT | 5 | 2 | 0 | 3 | 0 | 0 | 0 | 5 | 56.48 | 29.58 | 2746.94 | 1419.60 | |
% | ALL | MALES | FEMALES | UNKNOWN GENDER | MEDULLOBLASTOMA | ATRT | GERMINOMA | CONTROLS | |||||
ALL | 100.00% | ||||||||||||
MALES | 50.93% | ||||||||||||
FEMALES | 28.57% | ||||||||||||
UNKNOWN GENDER | 19.88% | ||||||||||||
MEDULLOBLASTOMA | 11.80% | 4.97% | 4.35% | 2.48% | |||||||||
ATRT | 4.97% | 0.62% | 1.86% | 2.48% | |||||||||
GERMINOMA | 7.45% | 0.00% | 0.00% | 7.45% | |||||||||
CONTROLS | 75.16% | 45.34% | 22.36% | 7.45% | |||||||||
FETAL | 47.20% | 24.84% | 19.88% | 2.48% | 0.00% | 0.00% | 0.00% | 47.20% | |||||
INFANT | 11.80% | 9.32% | 2.48% | 0.00% | 0.62% | 1.24% | 0.00% | 9.94% | |||||
CHILD | 24.84% | 5.59% | 6.21% | 13.04% | 9.32% | 3.73% | 5.59% | 6.21% | |||||
ADOLESCENT | 3.73% | 1.86% | 0.00% | 1.86% | 1.86% | 0.00% | 1.86% | 0.00% | |||||
ADULT | 3.11% | 1.24% | 0.00% | 1.86% | 0.00% | 0.00% | 0.00% | 3.11% |